Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Matrix metalloproteinase-9 (MMP9) mRNA transcript is the messenger RNA template that encodes the MMP9 enzyme, a secreted zinc-dependent endopeptidase involved in extracellular matrix (ECM) remodeling, tissue repair, and inflammatory signaling. Under pathological conditions, such as amyotrophic lateral sclerosis (ALS), glioblastoma, and chronic inflammatory or fibrotic disorders, MMP9 expression is aberrantly upregulated. In the central nervous system, microglia-derived MMP9 degrades neuroprotective perineuronal nets and drives neuroinflammation, leading to motor neuron vulnerability and death. Historically, targeting the MMP9 protein with small molecules or antibodies has been hindered by poor selectivity and off-target toxicities. Consequently, therapeutic strategies have shifted toward targeting the MMP9 mRNA transcript directly using RNA-targeted modalities, such as antisense oligonucleotides (ASOs) like APRTX-003 and small interfering RNAs (siRNAs). These approaches utilize sequence-specific hybridization to trigger RNase H-mediated degradation or RNA interference (RNAi) machinery, effectively knocking down MMP9 expression at the source. This precise modulation of the MMP9 pathway offers a promising avenue to slow neurodegeneration and reduce pathological tissue remodeling while minimizing off-target effects.
Antisense oligonucleotide-mediated mRNA degradation, RNA interference (RNAi)-mediated mRNA cleavage, and translation inhibition
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Matrix metalloproteinase-9 mRNA transcript (MMP9 mRNA).